Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: An analysis of pooled trials
Authors:
- Robert S. FinkelhorRFRobert S. Finkelhor
- Randall D. CebulRCRandall D. Cebul
- 1 January 1995
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 129 (1) , 71-75
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Usefulness of transesophageal echocardiography to screen for left atrial thrombus before elective cardioversion for atrial fibrillationThe American Journal of Cardiology, 1993
- Cerebral thromboembolization after cardioversion of atrial fibrillation in patients without transesophageal echocardiographic findings of left atrial thrombusAmerican Heart Journal, 1993
- Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patientsAmerican Heart Journal, 1993
- Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillationAmerican Heart Journal, 1986
- Cardioversion and defibrillationAmerican Heart Journal, 1980
- Relation between echocardiographically determined left atrial size and atrial fibrillation.Circulation, 1976
- The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillationThe American Journal of Cardiology, 1969
- Arrhythmias Related to CardioversionCirculation, 1964
- Experience with “cardioversion” of atrial fibrillation and flutterThe American Journal of Cardiology, 1964
- Factors Influencing Conversion of Chronic Atrial Fibrillation with Special Reference to Serum Quinidine ConcentrationCirculation, 1956